Vaginal Swab Positive for Lactobacillus crispatus
A vaginal swab positive for Lactobacillus crispatus indicates a healthy vaginal microbiome and requires no treatment. This finding represents normal vaginal flora and is actually protective against vaginal infections.
What This Finding Means
Lactobacillus crispatus is the gold standard marker of vaginal health 1. The presence of L. crispatus in the vagina indicates:
- Normal, healthy vaginal flora - L. crispatus is the predominant beneficial bacterium in healthy women 2
- Protection against infections - It produces copious amounts of lactic acid that acts as a broad-spectrum bactericide and virucide 1
- Low risk for bacterial vaginosis (BV) - Women colonized with L. crispatus have significantly lower susceptibility to developing BV 3
- Optimal vaginal pH - Maintains the normal acidic pH (≤4.5) that prevents pathogen overgrowth 4, 2
The CDC guidelines explicitly state that bacterial vaginosis occurs when there is "replacement of the normal H2O2-producing Lactobacillus spp in the vagina with high concentrations of anaerobic bacteria" 2, 5, 2. Your patient has the opposite situation - they have the protective lactobacilli present.
Clinical Management
No treatment is indicated. The guidelines are clear that:
- "Identifying Candida [or other organisms] in the absence of symptoms should not lead to treatment, because approximately 10%-20% of women normally harbor" various organisms in the vagina 4, 2
- Only symptomatic disease requires treatment 2, 5
If the Patient Has Symptoms
If your patient is experiencing vaginal symptoms despite having L. crispatus present, you need to:
- Look for co-infections - L. crispatus can coexist with pathogens like Candida or Trichomonas 4, 2
- Perform complete evaluation including:
- Vaginal pH measurement (normal is ≤4.5)
- Wet mount microscopy for yeast, pseudohyphae, or motile trichomonads
- KOH preparation and whiff test
- Assessment for clue cells
- Consider non-infectious causes - Mechanical or chemical irritation, allergic reactions 2
Important Context from Recent Research
Recent high-quality studies demonstrate that L. crispatus is so beneficial that it's now being developed as a therapeutic probiotic for treating bacterial vaginosis 6, 7, 8. In a 2025 randomized controlled trial, vaginal administration of L. crispatus after metronidazole treatment for BV resulted in 41% colonization at 4 weeks and reduced inflammatory markers 6. Multiple 2023-2026 studies show that both oral and vaginal L. crispatus probiotics effectively treat BV and vulvovaginal candidiasis 9, 3, 7, 8.
The key point: If L. crispatus is being used therapeutically to restore vaginal health, finding it naturally present means your patient already has what we're trying to achieve in diseased patients.
Common Pitfalls to Avoid
- Do not treat asymptomatic colonization - This is normal flora, not an infection
- Do not prescribe antibiotics - This would destroy the protective lactobacilli and potentially cause bacterial vaginosis
- Do not confuse with Gardnerella vaginalis - While G. vaginalis culture is not specific (found in 50% of normal women), L. crispatus is definitively protective 2
Reassure your patient that this finding indicates vaginal health, not disease.